Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Aug;139(8):1469-79.
doi: 10.1038/sj.bjp.0705379.

Action potential changes associated with a slowed inactivation of cardiac voltage-gated sodium channels by KB130015

Affiliations

Action potential changes associated with a slowed inactivation of cardiac voltage-gated sodium channels by KB130015

R Macianskiene et al. Br J Pharmacol. 2003 Aug.

Abstract

1. We have studied the acute cardiac electrophysiological effects of KB130015 (KB), a drug structurally related to amiodarone. Membrane currents and action potentials were measured at room temperature or at 37 degrees C during whole-cell patch-clamp recording in ventricular myocytes. Action potentials were also measured at 37 degrees C in multicellular ventricular preparations. 2. The effects of KB were compared with those of anemone toxin II (ATX-II). Both KB and ATX-II slowed the inactivation of the voltage-gated Na(+) current (I(Na)). While KB shifted the steady-state voltage-dependent inactivation to more negative potentials, ATX-II shifted it to more positive potentials. In addition, while inactivation proceeded to completion with KB, a noninactivating current was induced by ATX-II. 3. KB had no effect on I(K1) but decreased I(Ca-L) The drug also did not change I(to) in mouse myocytes. 4. The action potential duration (APD) in pig myocytes or multicellular preparations was not prolonged but often shortened by KB, while marked APD prolongation was obtained with ATX-II. Short APDs in mouse were markedly prolonged by KB, which frequently induced early afterdepolarizations. 5. A computer simulation confirmed that long action potentials with high plateau are relatively less sensitive to a mere slowing of I(Na) inactivation, not associated with a persisting, noninactivating current. In contrast, simulated short action potentials with marked phase-1 repolarization were markedly modified by slowing I(Na) inactivation. 6 It is suggested that a prolongation of short action potentials by drugs or mutations that only slow I(Na) inactivation does not necessarily imply identical changes in other species or in different myocardial regions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of the effects of KB and ATX-II on voltage-dependent Na+ current (INa). (a,b) INa traces elicited by depolarizations to various potentials before (upper panels) and following 10-min exposure (lower panels) to 10 μM KB (a) or 200 nM ATX-II (b). Inset in (a): voltage pulse protocol. Holding potential (VH): −80 mV. Test potentials between −120 and 0 mV (a) or +20 mV (b). (c,d) Average normalized INa traces at −30 mV in the presence of 10 μM KB (c; n=5) or 200 nM ATX (d; n=4). INa in the presence of drug in each cell was normalized relative to the INa peak amplitude before exposure to the drug in the same cell. Inset in (d) superimposed traces from (c) and (d) shown at different current gain. The horizontal dashed lines indicate zero current level. Pig ventricular myocytes. [Na]o=[Na]i=10 mM; K+-free, Cs+-containing external and internal solutions; room temperature.
Figure 2
Figure 2
Comparison of the effects of KB and ATX-II on voltage-dependent inactivation of INa. (a,b) Superimposed INa traces, elicited by depolarizations to −30 mV following 1-s prepulses to various levels (upper panels), and inactivation curves (lower panels) in the absence (unfilled circles) and in the presence (filled circles) of either 10 μM KB (a) or 200 nM ATX-II (b). Inset in (a): voltage pulse protocol. Holding potential (VH): −80 mV. Horizontal dashed lines indicate zero current level. Fitting of the inactivation curves was made using Boltzmann distribution functions. Average parameters of the Boltzmann functions for ATX: V0.5=−83±2.85 mV, slope=5.7±0.3, in control; V0.5=−72±3.7 mV, slope=7.5±0.4, in the presence of the toxin (n=4; P<0.05 vs control). For average KB data, see Macianskiene et al. (2003). (c,d) Pooled data on peak amplitude of INa at −30 mV using VH of either −120 or −80 mV in control (unfilled columns) and in the presence (hatched columns) of 10 μM KB (c; n=5–6) or 200 nM ATX-II (d; n=4). Pig ventricular myocytes. [Na]o=[Na]i=10 mM; K+-free, Cs+-containing external and internal solutions; room temperature. **P<0.01 for drug vs control (paired t-test).
Figure 3
Figure 3
Comparison of KB and ATX-II effects on INa and action potentials in pig cardiac myocytes. (a,b) Superimposed INa traces induced at −30 mV in control (unfilled circles) and in the presence (filled circles) of either 10 μM KB (a) or 200 nM ATX-II (b). (c,d) Superimposed action potential recorded under current-clamp conditions in the same cells, in control (unfilled circles) and in the presence (filled circles) of either 10 μM KB (c) or 200 nM ATX-II (d). In (d) action potential labeled with unfilled square was obtained after 10-min washout of ATX-II. Horizontal dashed lines indicate 0 mV level. Stimulation via the patch pipette at 1 Hz. [Na]o=150 mM, [Na]i=10 mM; K+-containing external and internal solutions; ruptured-patch recording; room temperature.
Figure 4
Figure 4
Variable effects of KB on action potentials in pig preparations. Superimposed action potential traces (leftmost and middle panels; different cells) recorded in control (unfilled circles) and in the presence of 10 μM KB (filled circles), and average durations (columns; rightmost panels) of the APD at 50% (APD50) and 90% repolarization (APD90). Horizontal dotted lines indicate 0 mV level. Pacing frequency: 1 Hz. (a) Pig ventricular myocytes; room temperature; (b) pig ventricular trabecula; 37°C.
Figure 5
Figure 5
Effect of KB on action potentials in mouse myocytes. (a) Action potentials measured in control, at 5 and 10 min after application of 10 μM KB, and following 60-min washout of KB in 0.1% DMSO. Myocyte from the left ventricular free wall; ruptured patch recording. (b,c) Action potential recorded in control and in the presence of 3 or 10 μM KB; perforated patch recordings. Myocytes from the left ventricular free wall (b) and from the septum (c). Horizontal dashed lines indicate zero level; pacing at 1 Hz.
Figure 6
Figure 6
Effect of KB on steady-state currents. (a, b) Traces of currents elicited by 1-s steps to various potentials before (upper panels) and after application (lower panels) of either 10 μM KB (a) or 200 nM ATX-II (b). Horizontal dashed lines indicate zero current level. (c, d) Current–voltage relations in control (unfilled circles) and in the presence (filled circles) of either 10 μM KB (c) or 200 nM ATX-II (d). Currents measured at the end of the 1-s pulse. Notice the change of steady-state currents by ATX-II but not KB at potentials positive to −70 mV. Pig ventricular myocytes; K+-containing external and internal solutions; [Na]o=150 mM; [Na]i=10 mM; room temperature.
Figure 7
Figure 7
KB effect on the L-type Ca2+ current (ICa-L). (a) ICa-L currents elicited by steps to various potentials in the absence (left) and in the presence (right) of 10 μM KB. The horizontal dotted line indicates zero current level. Inset in left panel shows the voltage protocol: holding potential (VH) of −80 mV, prestep for 1 s to −40 mV to inactivate INa and any T-type Ca2+ current. Inset in right panel contrasts the failure of KB to change the time course ICa-L (at 0 mV) at a time when it causes slowing of INa (during the prestep to −40 mV). (b) Current–voltage relations in control (unfilled circles) and in the presence (filled circles) of 10 μM KB. Pooled data from various cells (n=9). (c) Time constants (obtained using biexponential fitting) of ICa-L inactivation measured at 0 mV, in control conditions (unfilled columns) and in 10 μM KB (filled columns). Same cells as in (b) pig myocytes; K+-free, Cs+-containing external and internal solutions; room temperature. *P<0.05 vs control.
Figure 8
Figure 8
Lack of effect of KB on Ito and IK1 in mouse myocytes. (a) Traces of currents elicited by steps to various potentials before (left panel) and after application (right panel) of 10 μM KB. Horizontal dotted lines indicate zero current level. (b) Current–voltage relations in control (unfilled circles) and in the presence (filled circles) of 10 μM KB. Currents measured at peak level. (c) Pooled data on amplitude of currents at −120 mV (largely IK1; n=10) and +60 mV (largely Ito; n=3). Notice lack of KB effect. [Na]o=[Na]i=0 mM; K+-containing external and internal solutions; room temperature.
Figure 9
Figure 9
Simulation of the effect of slowed INa inactivation on the action potential. Na+ currents (INa) and action potentials generated using different channel kinetic parameters. Upper panels: INa induced by simulated voltage-clamp from −80 to −30 mV. Middle panels: action potentials generated during simulated pacing at 1 Hz in the absence of the transient outward current (Ito). Lower panels: action potentials in the presence of a large Ito (maximal conductance 4 μS pF−1). (a) Control conditions. Na+ channel with standard kinetics and conductance, as given in the Luo–Rudy model formulated from single channel kinetics (Clancy & Rudy, 1999). (b) Na+ channel with slowed inactivation kinetics but normal maximal conductance. The default rate constants of transitions from the open to the inactivated state (α2) and from the closed to the open state (α13) were decreased by a factor of 20 and 3.8, respectively, whereas the rate constant for the recovery from the inactivated to the closed state (α3) was changed by a factor of 10. α2=0.459 × elV/29.68 m s−1; α13=1/(0.1027 × eV/12+0.25 × eV/150) m s−1; α3=3.79 × 10−8 × eV/5.2 m s−1. (c) Na+ channel with slowed inactivation kinetics and decreased maximal conductance. The rate constant α2 and the maximal conductance (GNa) were decreased. α2=0.2 × eV/29.68 m s−1; GNa=3 instead of 16 μS pF−1.

Similar articles

Cited by

References

    1. AMOS G.J., RAVENS U. The inotropic agents DPI 201-106 and BDF 9148 differentially affect potassium currents of guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch. Pharmacol. 1994;350:426–433. - PubMed
    1. BALSER J.R. The cardiac sodium channel: gating function and molecular pharmacology. J. Mol. Cell. Cardiol. 2001;33:599–613. - PubMed
    1. BENNETT P.B. Long QT syndrome: biophysical and pharmacologic mechanisms in LQT3. J. Cardiovasc. Electrophysiol. 2000;11:819–822. - PubMed
    1. BEZZINA C.R., ROOK M.B., WILDE A.A. Cardiac sodium channel and inherited arrhythmia syndromes. Cardiovasc. Res. 2001;49:257–271. - PubMed
    1. BOUTJDIR M., RESTIVO M., WEI Y., STERGIOPOULOS K., EL-SHERIF N. Early afterdepolarization formation in cardiac myocytes: analysis of phase plane patterns, action potential, and membrane currents. J. Cardiovasc. Electrophysiol. 1994;5:609–620. - PubMed

Publication types

LinkOut - more resources